In some embodiments, local otic delivery of the auris formulations or compositions described herein allows for controlled release of active agents to auris structures and overcomes the drawbacks associated with systemic administration (e.g., low bioavailability of the drug in the endolymph or perilymph, variability in concentration of the drug in the external, middle and/or internal ear)
Draw up exactly 10 units for each injection
Note that CJC-1295 no DAC is essentially the tetrasubstituted version of the smallest GHRH-analog GRF (1-29), aka sermorelin
At that time, the animals were sacrificed to extract lung, liver, spleen and brain, and to determine the bacterial load from homogenates obtained from each organ
Muscle fiber cross-sectional area increases at approximately 1.52% per week under optimal conditions (progressive overload, caloric surplus, 4080mcg IGF-1 LR3 daily)
In other embodiments, the pharmaceutical formulations or compositions also contain other therapeutic substances